Mdm4-flox Mouse

Mdm4, also known as MDMX or HDMX (human MDMX), is a crucial negative regulator of the tumor suppressor p53 [6,7,8]. It is involved in cell proliferation, DNA repair, and apoptosis regulation, and its normal function is essential for maintaining proper cell function and response to stress [1,7]. Through its N-terminus transactivation domain engaging p53 and C-terminus RING domain binding to MDM2, Mdm4 restricts p53 transcriptional activity and, at least in development, aids MDM2's E3 ligase activity toward p53 [7].

MDM4 overexpression and amplification are linked to cancer formation, metastasis, and poor disease prognosis [1]. It is frequently amplified and upregulated in human cancers, blocking the expression of downstream target genes of the p53 pathway, contributing to overgrowth and apoptosis inhibition [3]. Some MDM4 SNPs in non-coding regions can affect its regulation by disrupting microRNA binding sites in 3'UTR, but studies on the association between its SNPs and cancer risk in different populations have led to conflicting conclusions [1]. MDM4 generates two mutually exclusive isoforms via alternative splicing: MDM4-FL encoding the full-length protein and MDM4-S, with previous results suggesting MDM4-S could be a tumor driver, though recent data indicate it may be a passenger isoform during tumorigenesis [2]. In p53 mutant colon cancer, MDM4 inhibits ferroptosis by regulating TRIM21/GPX4 expression, promoting cancer progression [4]. Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis [5].

In conclusion, Mdm4 is a key negative regulator of p53, playing a significant role in cancer and pulmonary fibrosis. Its overexpression and genetic variations are associated with disease development. Research on Mdm4, especially through in vivo studies like potential KO/CKO mouse models (not directly mentioned in provided refs but relevant in general functional studies), helps understand its functions in disease-related biological processes, offering potential therapeutic strategies for cancer and pulmonary fibrosis [1,3,4,5].